Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06565637 · ClinicalTrials.gov registry record · Phase 1
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
A Phase 1 study of Eating Disorders and Sexual Minorities, sponsored by Auburn University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT06565637 is a Phase 1 study of Eating Disorders and Sexual Minorities that is actively recruiting participants, run by Auburn University. The registered enrollment target is 30 participants, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06565637, a Phase 1 study of Eating Disorders and Sexual Minorities, is actively recruiting participants, sponsored by Auburn University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to learn if a new intervention (Promoting Resilience to Improve Disordered Eating; PRIDE) can decrease internalized stigma and increase the ability to cope effectively with stressors in sexual minority populations diagnosed with eating disorders. The main question it aims to answer is: Will an eating disorders treatment focused on decreasing internalized stigma and increasing sexual minority stress coping self efficacy in sexual minority populations? Participants Will * Complete a telephone screen with study staff to determine preliminary eligibility for the study * Undergo a behavioral eligibility screening that includes structured clinical interviewing in order to determine proper diagnosis of an eating disorder along with ensuring absence of non-eating disorder diagnoses * Complete self-report measures to determine study eligibility * Attend up to 14 weekly therapy sessions as part of the PRIDE intervention, where participants will work with qualified clinicians to address eating pathology and disordered body image along with developing effective strategies for coping with sexual minority stressors * Complete surveys upon completion of the intervention 3 and 6 months post follow-up
Conditions Studied
Interventions
- BEHAVIORAL Promoting Resilience to Improve Disordered Eating
Study Locations (2)
Alabama
- Auburn University - Auburn
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2026-07-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06565637
The ClinicalTrials.gov registry entry for NCT06565637 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (91% lower). The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Eating Disorders appearing as the primary indexed condition, and to 1 intervention - of which Promoting Resilience to Improve Disordered Eating is the first listed.
NCT06565637 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, California.
Frequently Asked Questions
What is clinical trial NCT06565637 about?
NCT06565637 is a clinical study titled "Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders". The goal of this clinical trial is to learn if a new intervention (Promoting Resilience to Improve Disordered Eating; PRIDE) can decrease internalized stigma and increase the ability to cope effectively with stressors in sexual minority populations diagnosed with eating disorders. The main question ...
What is the current status of trial NCT06565637?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2025-02-28. Estimated completion is 2026-07-01.
What conditions does trial NCT06565637 study?
This clinical trial studies the following conditions: Eating Disorders, Sexual Minorities.
What interventions are being tested in trial NCT06565637?
The interventions under investigation include: Promoting Resilience to Improve Disordered Eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT06565637?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06565637 being conducted?
This trial has 2 study locations across Alabama, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Diabetes Body Project 2
RECRUITING · NA
-
Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.